These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6860532)

  • 21. Do diuretics have antihypertensive properties independent of natriuresis?
    Bennett WM; McDonald WJ; Kuehnel E; Hartnett MN; Porter GA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):499-504. PubMed ID: 334435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation, Characterization, and the Diuretic Effects of a New Intravenous Metolazone Emulsion.
    Ahlschwede KM; Ofori E; Andey T; Osei A; Somberg JS
    Drug Res (Stuttg); 2022 Jul; 72(6):299-305. PubMed ID: 35537450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose diuretic therapy for hypertension.
    Moser M
    Clin Ther; 1986; 8(5):554-62. PubMed ID: 3768929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.
    Roberts CJ; Marshall AJ; Heaton S; Barritt DW
    Br Med J; 1979 Jan; 1(6158):224-6. PubMed ID: 369652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of diuretics on extrarenal potassium tolerance.
    Tanoue LT; Aronson PS; Bia MJ
    Yale J Biol Med; 1982; 55(5-6):421-8. PubMed ID: 7183021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of the synergistic combination of metolazone and bumetanide.
    Brater DC; Pressley RH; Anderson SA
    J Pharmacol Exp Ther; 1985 Apr; 233(1):70-4. PubMed ID: 3981464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-dosing metolazone with loop diuretic combination regimens.
    Lorenz RA; Elwell RJ
    Nephrol Nurs J; 2006; 33(1):78-9. PubMed ID: 16538931
    [No Abstract]   [Full Text] [Related]  

  • 29. Step 1 1/2 therapy for the treatment of hypertension.
    Miller SA; Cobb SD; Petrulis AS; Vertes V
    Ohio State Med J; 1985 Jan; 81(1):57, 59-61, 63. PubMed ID: 3881712
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of diuretic therapy on adrenaline-induced hypokalaemia and hypomagnesaemia.
    Whyte KF; Whitesmith R; Reid JL
    Eur J Clin Pharmacol; 1988; 34(4):333-7. PubMed ID: 3402518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertension.
    Curry CL; Janda SM; Harris R; MacKay JH; Nugent CA; Ryan J; Schnaper H; Schoenberger J
    Clin Ther; 1986; 9(1):47-62. PubMed ID: 3545477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of metolazone in the treatment of ascites due to liver disease.
    Hillenbrand P; Sherlock S
    Br Med J; 1971 Oct; 4(5782):266-70. PubMed ID: 5123909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension.
    Charansonney OL; Lièvre M; Laville M; Lion L; Derobert E; Visèle N; Decourt S; de Rusunan MP; Luciani J; Vasmant D; Boissel JP; Grünfeld JP
    Therapie; 1997; 52(3):169-77. PubMed ID: 9366100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs.
    Jeunesse E; Woehrle F; Schneider M; Lefebvre HP
    J Vet Cardiol; 2007 Nov; 9(2):63-8. PubMed ID: 18024236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 36. A fluorimetric assay for metolazone in urine.
    Vose CW; Stevens PM; Muirhead DC; Palmer RF; McInnes GT
    Br J Clin Pharmacol; 1980 Feb; 9(2):213-5. PubMed ID: 7356909
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man.
    Erbler H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276539
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of metolazone and furosemide in children with furosemide-resistant edema.
    Arnold WC
    Pediatrics; 1984 Nov; 74(5):872-5. PubMed ID: 6493882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacology of potassium-sparing diuretics].
    Dominiak P
    Praxis (Bern 1994); 1997 Apr; 86(14):552-5. PubMed ID: 9198848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.